週边血管介入市场规模、份额和成长分析（按介入类型、器械类型、适应症、技术、最终用户和地区划分）- 产业预测（2026-2033 年）

预计到 2024 年，週边血管介入市场规模将达到 111.3 亿美元，到 2025 年将达到 121.4 亿美元，到 2033 年将达到 243.7 亿美元，在预测期（2026-2033 年）内，复合年增长率为 9.1%。

心血管疾病盛行率的上升是推动週边血管介入治疗需求成长的主要因素。高血压、糖尿病、肥胖、吸烟和高碳水化合物摄取等风险因素显着增加了各种心血管疾病的发生率。为此，全球范围内导管介入检查室的建设正在不断扩展。这一趋势在新兴市场尤为显着，这些市场中专攻此类手术的医疗专业人员数量正在增加。这种成长凸显了导管介入检查室在心血管疾病诊断和治疗中的重要性，其应用正在加速，尤其是在发展中地区。混合型导管介入检查室的出现也值得关注，它们能够进行包括血管内介入和神经介入在内的多种临床手术。总而言之，週边血管介入治疗日益专业化以及血管成形术等手术医疗费用支出的不断增长，都预示着该行业将迎来强劲的成长。

週边血管介入市场驱动因素

心血管疾病，尤其是周边动脉疾病（PAD）发生率的不断上升，是推动週边血管介入治疗需求成长的主要因素。心血管疾病的激增受多种危险因子的影响，包括高血压、糖尿病、肥胖和缺乏运动。随着这些健康问题的日益普遍，对有效週边血管治疗的需求也随之增加，凸显了医疗技术和治疗策略进步对于解决这些问题的关键意义。这种医疗重点的转变不仅强调了控制现有疾病的重要性，也促进了旨在减轻心血管疾病整体负担的预防和宣传工作。

限制週边血管介入市场发展的因素

週边血管介入治疗市场面临许多限制因素，其中高昂的治疗费用可能成为许多患者的障碍。在许多已开发地区，医疗成本负担已成为患者获得所需治疗的一大障碍。医疗技术的日益复杂和进步进一步加剧了这个问题，因为这些往往意味着手术和治疗费用的上涨。因此，经济资源有限的患者难以获得适当的医疗服务，最终限制了市场的整体成长潜力，并减少了能够从这些重要的周边血管介入治疗中获益的患者数量。

週边血管介入市场趋势

週边血管介入市场的一大趋势是建立综合性导管检查室，这些导管室整合了多种介入治疗方法，包括心臟、血管、神经和电生理手术。这种向混合设施的转变源于其多功能性、提供全面护理的能力，以及更高的手术效率和更好的患者预后。人们对这种适应性环境的日益青睐反映了治疗模式的更广泛转变，使医疗服务提供者能够提供满足不同患者需求的多学科治疗方法。随着这些创新导管室的普及，预计它们将增强週边血管介入市场，并推动技术和介入策略的进步。

目录

介绍

• 分析目的
• 分析范围
• 定义

分析方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场进行机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特五力分析

关键市场考量因素

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场魅力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球週边血管介入市场规模及依介入类型分類的复合年增长率（2026-2033 年）

• 动脉粥状硬化斑块切除术
• 支架置入术
• 血管成形术
• 血栓切除术
• 栓塞术

全球週边血管介入市场规模及按器械类型分類的复合年增长率（2026-2033 年）

• 导管
• 支架
• 导管导引线
• 气球
• 栓塞线圈

全球週边血管介入市场规模及依适应症分類的复合年增长率（2026-2033 年）

• 冠状动脉疾病
• 中风
• 周边动脉疾病
• 肾动脉狭窄
• 颈动脉狭窄

全球週边血管介入市场规模及依技术分類的复合年增长率（2026-2033 年）

• 药物释放型支架
• 球囊扩张型支架
• 自动扩张型支架
• 旋切动脉粥状硬化斑块切除术
• 定向斑块动脉粥状硬化斑块切除术

全球週边血管介入市场规模及依最终用户分類的复合年增长率（2026-2033 年）

• 医院
• 门诊手术中心
• 诊所
• 研究所

全球週边血管介入市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争格局

• 前五大公司对比
• 主要企业市场定位（2025 年）
• 主要企业采取的策略
• 近期市场趋势
• 主要企业市占率（2025 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 年比营收比较（2023-2025）

主要企业简介

• 美敦力公司（爱尔兰）
• 雅培实验室（美国）
• 波士顿科学公司（美国）
• 贝克顿·迪金森公司（BD）（美国）
• Philips（Netherlands）
• 泰尔茂株式会社（日本）
• 库克医疗（美国）
• 康德乐公司（美国）
• B.Braun Melsungen AG（德国）
• Getinge AB（瑞典）
• Merit Medical Systems, Inc.（美国）
• BIOTRONIK SE & Co. KG（德国）
• Endologix公司（美国）
• ArtVentive医疗集团有限公司（美国）
• Inari Medical, Inc.（美国）
• Bentley InnoMed GmbH（德国）
• 戈尔医疗（美国）
• 微创医疗（中国）

结论与建议

Peripheral Interventions Market size was valued at USD 11.13 Billion in 2024 and is poised to grow from USD 12.14 Billion in 2025 to USD 24.37 Billion by 2033, growing at a CAGR of 9.1% during the forecast period (2026-2033).

The rising prevalence of cardiovascular disorders is a primary driver of demand for peripheral interventions. Contributing risk factors such as hypertension, diabetes, obesity, smoking, and high carbohydrate intake significantly increase the incidence of various cardiovascular diseases. In response, the establishment of catheterization laboratories is expanding globally, especially in emerging markets, alongside a growing number of healthcare professionals specializing in these procedures. This surge underscores the importance of cath labs for diagnosing and treating cardiovascular conditions, with their adoption particularly increasing in developing regions. The emergence of hybrid catheterization labs, which facilitate a range of clinical procedures including vascular and neurological interventions, is also notable. Overall, the increasing specialization in peripheral interventions and the rise in healthcare spending on procedures like angioplasties signal robust industry growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Interventions market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peripheral Interventions Market Segments Analysis

Global Peripheral Interventions Market is segmented by Intervention Type, Device Type, Indication, Technology, End User and region. Based on Intervention Type, the market is segmented into Atherectomy, Stent Implantation, Angioplasty, Thrombectomy and Embolization. Based on Device Type, the market is segmented into Catheters, Stents, Guide Wires, Balloons and Embolic Coils. Based on Indication, the market is segmented into Coronary Artery Disease, Stroke, Peripheral Arterial Disease, Renal Artery Stenosis and Carotid Artery Stenosis. Based on Technology, the market is segmented into Drug-Eluting Stents, Balloon-Expandable Stents, Self-Expanding Stents, Rotational Atherectomy and Directional Atherectomy. Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, Clinics and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Peripheral Interventions Market

The increasing occurrence of cardiovascular diseases, particularly peripheral artery disease (PAD), significantly fuels the demand for peripheral interventions. This surge in cardiovascular conditions is influenced by various risk factors, including hypertension, diabetes, obesity, and a lack of physical activity. As these health issues become more widespread, the necessity for effective peripheral treatments grows, highlighting a crucial need for advancements in medical technologies and therapeutic strategies to address these concerns. This shift in healthcare focus not only emphasizes the importance of managing existing conditions but also encourages prevention and awareness initiatives aimed at reducing the overall burden of cardiovascular diseases.

Restraints in the Peripheral Interventions Market

The Peripheral Interventions market faces significant limitations due to the high costs associated with treatments, which can pose a barrier for many individuals seeking care. In many developed regions, the financial burden of healthcare can hinder patients from accessing necessary interventions. This situation is exacerbated by the complexity and advancements in medical technology, which often translate to higher prices for procedures and treatments. As a result, those with limited financial resources may struggle to receive appropriate care, ultimately restricting the overall growth potential of the market and limiting the number of patients who can benefit from these essential peripheral interventions.

Market Trends of the Peripheral Interventions Market

The Peripheral Interventions market is witnessing a significant trend towards the establishment of heterogeneous catheterization labs, which are increasingly integrating various invasive interventional treatments, including cardiac, vascular, neurological, and electrophysiological procedures. This shift towards hybrid facilities is driven by their versatility and the ability to deliver comprehensive care, enhancing procedural efficiency and patient outcomes. The growing preference for these adaptable environments reflects a broader transformation in treatment paradigms, enabling healthcare providers to offer multidisciplinary approaches that address diverse patient needs. As these innovative labs gain traction, they are set to strengthen the Peripheral Interventions market, fostering advancements in technology and interventional strategies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Peripheral Interventions Market Size by Intervention Type & CAGR (2026-2033)

• Market Overview
• Atherectomy
• Stent Implantation
• Angioplasty
• Thrombectomy
• Embolization

Global Peripheral Interventions Market Size by Device Type & CAGR (2026-2033)

• Market Overview
• Catheters
• Stents
• Guide Wires
• Balloons
• Embolic Coils

Global Peripheral Interventions Market Size by Indication & CAGR (2026-2033)

• Market Overview
• Coronary Artery Disease
• Stroke
• Peripheral Arterial Disease
• Renal Artery Stenosis
• Carotid Artery Stenosis

Global Peripheral Interventions Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Drug-Eluting Stents
• Balloon-Expandable Stents
• Self-Expanding Stents
• Rotational Atherectomy
• Directional Atherectomy

Global Peripheral Interventions Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Clinics
• Research Institutes

Global Peripheral Interventions Market Size & CAGR (2026-2033)

• North America (Intervention Type, Device Type, Indication, Technology, End User)
  • US
  • Canada
• Europe (Intervention Type, Device Type, Indication, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Intervention Type, Device Type, Indication, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Intervention Type, Device Type, Indication, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Intervention Type, Device Type, Indication, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endologix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ArtVentive Medical Group, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inari Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bentley InnoMed GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gore Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations